BioLife Solutions Inc (OQ:BLFS)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: SUITE 310, 3303 MONTE VILLA PARKWAY
BOTHELL WA 98021
Tel: 1-425-4021400
Website: https://www.biolifesolutions.com
IR: See website
<
Key People
Roderick De Greef
Chairman of the Board, Chief Executive Officer, President
Troy Wichterman
Chief Financial Officer
Aby J. Mathew
Executive Vice President, Chief Scientific Officer
Geraint Phillips
Senior Vice President - Global Operations
Todd Berard
Chief Marketing Officer
Sarah Aebersold
Vice President - Global Human Resources
Karen A. Foster
Chief Quality Officer
Garrie Richardson
Chief Revenue Officer
 
Business Overview
BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Its expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage and distribution. Its biopreservation media products, HypoThermosol FRS and CryoStor Freeze Media, are formulated to mitigate preservation-induced, delayed-onset cell damage and death which result when cells and tissues are subjected to reduced temperatures. Its bioproduction tools portfolio includes human platelet lysates for cell expansion. It is a provider of biological and pharmaceutical storage and cold chain logistics. Its monitoring systems allow customers real time tracking of the storage temperatures of their materials throughout the logistics process. It operates about five storage facilities in the United States and one facility in the Netherlands.
Financial Overview
For the fiscal year ended 31 December 2023, BioLife Solutions Inc revenues decreased 11% to $143.3M. Net loss decreased 52% to $66.4M. Revenues reflect Product Revenue-Freezer and thaw segment decrease of 24% to $50.6M, Product Revenue-Cell processing segment decrease of 4% to $65.8M, United States segment decrease of 2% to $114.6M, Other Countries segment decrease of 11% to $5.7M.
Employees: 409 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $709.74M as of Dec 31, 2023
Annual revenue (TTM): $143.27M as of Dec 31, 2023
EBITDA (TTM): -$43.04M as of Dec 31, 2023
Net annual income (TTM): -$66.43M as of Dec 31, 2023
Free cash flow (TTM): -$23.74M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 45,300,000 as of Feb 22, 2024
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.